In addition to invasive or burdensome testing, such as ileocolonoscopy or enterography, current means of monitoring IBD activity between visits rely on the periodic assessment of inflammatory markers such as CRP and fecal calprotectin (Mosli et al., 2015). Here, CRP is linked to inflammatory bowel disease.